Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1232, 2000-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Atomoxetine: long-term treatment benefits in ADHD
Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. :
Long-term benefits of bosentan in pulmonary arterial hypertension
Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. :
Ziprasidone: long-term benefits in bipolar disorder
Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. :
Quinapril long-term benefits after coronary intervention
Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. :
Eptifibatide has long-term benefits post-PCI
Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. :